-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_policymaker.pdf
August 01, 2016 - Transitional Care Interventions To Prevent Readmissions for People With Heart Failure
B A C K G R O U N D
Heart failure (HF) is a major clinical and public
health problem and a leading cause of hospitalization
and health care costs in the United States. Despite a
decline in HF-related hospitalizations during the …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
January 01, 2013 - Enable participation by a large, geographically diverse participant pool;
Help accommodate participant schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - improve sleep (e.g., avoiding/
limiting caffeine, nicotine, and alcohol; maintaining a regular sleep schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/scope-communicating-evolving-evidence-white-paper_0.pdf
March 01, 2025 - Update report schedule with numbers of new studies added ............................................ … Update report schedule with numbers of new studies added
Report Abstracts
Reviewed
Full-Text
Reviewed
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
February 22, 2019 - Rating Scale (BPRS) Mood; Psychosis
clinician administered
interview Overall 1962; Beller 1984
Schedule … Disorders and Schizophrenia (SADS) Mood; Psychosis
clinician administered
interview Endicott 1978
Schedule … Schizophrenia -Lifetime version
(SADS-L) Mood; Psychosis
clinician administered
interview Endicott 1978
Schedule
-
effectivehealthcare-admin.ahrq.gov/products/care-interventions-pwd/protocol
August 01, 2020 - Mood; Psychosis
clinician administered interview
Overall 1962; Beller 1984
Schedule … Schizophrenia (SADS)
Mood; Psychosis
clinician administered interview
Endicott 1978
Schedule … (SADS-L)
Mood; Psychosis
clinician administered interview
Endicott 1978
Schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-key-question.pdf
December 19, 2023 - Moderate and ultra-hypofractionation schedules include fewer but higher dose fractions and shorter
overall
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - in PMD and
3
anticipated that an interim analysis of study data would take place ahead of schedule … Ketamine is classified as a Schedule III nonnarcotic controlled
11
substance and, at higher … And another expert postulated that the intravenous route of administration
and dosing schedule for … Controlled substance
schedules. [internet]. … Available:
http://www.deadiversion.usdoj.gov/schedules/.
94. Columbia University.
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-applicability/methods
May 01, 2020 - population in the community. 16
Event rates in treatment and control groups
Intervention
Doses or schedules … Most published trials, however, used up to 120 mg/d. 17
Dose, schedule, and duration of medication … compared 80 and 120 mg/d of duloxetine (high dose) with 20 mg of paroxetine (low dose). 22
Dose and schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - Lorcaserin has been scheduled as a Schedule IV drug, lifting the potential prescribing
limitations … Drug Enforcement Administration as a Schedule IV drug; it
became available for prescribing in June … Drug
Enforcement Administration (DEA) as a Schedule IV drug (i.e., with a low potential for
abuse … At the time of review, DEA
had not yet announced whether it would classify lorcaserin as a Schedule … III (i.e., drugs with
a moderate to low potential for physical and psychological dependence) or schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - ThromboGenics'
microplasmin phase III program progressing
according to schedule. [internet]. … www.bio-medicine.org/medicine-technology-1/ThromboGenics-Microplasmin-Phase-III-Program-Progressing-According-to-Schedule … www.bio-medicine.org/medicine-technology-1/ThromboGenics-Microplasmin-Phase-III-Program-Progressing-According-to-Schedule … www.bio-medicine.org/medicine-technology-1/ThromboGenics-Microplasmin-Phase-III-Program-Progressing-According-to-Schedule … www.bio-medicine.org/medicine-technology-1/ThromboGenics-Microplasmin-Phase-III-Program-Progressing-According-to-Schedule
-
effectivehealthcare-admin.ahrq.gov/products/heart-failure-transition-care/research-protocol
December 01, 2019 - instructions should address the following: activity level, diet, discharge medications, a followup appointment … instructions or other educational materials that address activity level, diet, discharge medications, followup appointment … ACC/AHA/AMA (American Medical Association) Performance Consortium added a documented postdischarge appointment … Predischarge interventions, such as:
HF-specific discharge planning
Medication reconciliation
Appointment
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
January 01, 2021 - Black women are more likely than white women
to schedule a uterine-sparing treatment for leiomyomas. … Schedule of Visits and Use of Telemedicine for Routine Antenatal Care https://go.usa.gov/xuxVY
17.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
July 01, 2016 - Nonsurgical treatments include dietary fiber supplementation,
bowel schedules, stool-modifying drugs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Drug Enforcement Administration (DEA) as a Schedule IV drug, which means DEA will
review FDA’s recommendation … Drug Enforcement Administration’s review of FDA’s recommendation to classify lorcaserin as
a Schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - population in the community.16
Event rates in treatment and control groups
Intervention Doses or schedules … Most published
trials, however, used up to 120 mg/d.17
Dose, schedule, and duration of
medication … compared 80 and 120 mg/d of duloxetine (high dose)
with 20 mg of paroxetine (low dose).22
Dose and schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - population in the community.16
Event rates in treatment and control groups
Intervention Doses or schedules … Most published
trials, however, used up to 120 mg/d.17
Dose, schedule, and duration of
medication … compared 80 and 120 mg/d of duloxetine (high dose)
with 20 mg of paroxetine (low dose).22
Dose and schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - National Institutes of Health Clinical Center (Bethesda, MD).
37-39
Ketamine is classified as a Schedule … Controlled substance
schedules. [internet]. … Available:
http://www.deadiversion.usdoj.gov/schedules/.
41. … show/NCT00548964
http://www.clinicaltrials.gov/ct2/show/NCT00548964
http://www.deadiversion.usdoj.gov/schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
September 06, 2023 - conducted as web conferences, and
we will invite key informants to individual interviews as their schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
September 06, 2023 - conducted as web conferences, and we will invite key informants to
individual interviews as their schedule